| Retinoic acid and arsenic trioxide for acute promyelocytic leukemia F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ... New England Journal of Medicine 369 (2), 111-121, 2013 | 1660* | 2013 |
| Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical … R Martino, S Iacobelli, R Brand, T Jansen, A van Biezen, J Finke, ... Blood 108 (3), 836-846, 2006 | 427 | 2006 |
| Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma … L Garderet, S Iacobelli, P Moreau, M Dib, I Lafon, D Niederwieser, ... Journal of clinical oncology 30 (20), 2475-2482, 2012 | 264 | 2012 |
| Response to rituximab-based therapy and risk factor analysis in Epstein Barr virus–related lymphoproliferative disorder after hematopoietic stem cell transplant in children and … J Styczynski, L Gil, G Tridello, P Ljungman, JP Donnelly, ... Clinical infectious diseases 57 (6), 794-802, 2013 | 250 | 2013 |
| Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors J Styczyński, G Tridello, L Koster, S Iacobelli, A van Biezen, ... Bone marrow transplantation 55 (1), 126-136, 2020 | 246 | 2020 |
| Dose-reduced versus standard conditioning followed by allogeneic stem-cell transplantation for patients with myelodysplastic syndrome: a prospective randomized phase III study … N Kröger, S Iacobelli, GN Franke, U Platzbecker, R Uddin, K Hübel, ... Journal of Clinical Oncology 35 (19), 2157-2164, 2017 | 233 | 2017 |
| Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning C Crawley, S Iacobelli, B Björkstrand, JF Apperley, D Niederwieser, ... Blood 109 (8), 3588-3594, 2007 | 230 | 2007 |
| Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study G Gahrton, S Iacobelli, B Björkstrand, U Hegenbart, A Gruber, H Greinix, ... Blood, The Journal of the American Society of Hematology 121 (25), 5055-5063, 2013 | 227* | 2013 |
| Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy DC Mastellos, BGPP da Silva, BAL Fonseca, NP Fonseca, ... Clinical Immunology 220, 108598, 2020 | 223 | 2020 |
| Antimicrobial resistance in Gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the Infectious … D Averbuch, G Tridello, J Hoek, M Mikulska, H Akan, ... Clinical Infectious Diseases 65 (11), 1819-1828, 2017 | 221 | 2017 |
| Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up B Björkstrand, S Iacobelli, U Hegenbart, A Gruber, H Greinix, L Volin, ... Journal of Clinical Oncology 29 (22), 3016-3022, 2011 | 217 | 2011 |
| Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia A Gratwohl, R Brand, J Apperley, A Biezen, G Bandini, A Devergie, ... Blood, The Journal of the American Society of Hematology 100 (12), 3877-3886, 2002 | 192 | 2002 |
| Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation S Iacobelli Bone marrow transplantation 48 (1), S1-S37, 2013 | 188 | 2013 |
| The effect of prior exposure to imatinib on transplant-related mortality M Deininger, M Schleuning, H Greinix, HG Sayer, T Fischer, J Martinez, ... Haematologica 91 (4), 452-459, 2006 | 148 | 2006 |
| Eltrombopag added to immunosuppression in severe aplastic anemia R Peffault de Latour, A Kulasekararaj, S Iacobelli, SR Terwel, R Cook, ... New England Journal of Medicine 386 (1), 11-23, 2022 | 140 | 2022 |
| Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR‐ligand mismatch after dose‐reduced conditioning and unrelated stem cell transplantation … N Kröger, B Shaw, S Iacobelli, T Zabelina, K Peggs, A Shimoni, A Nagler, ... British journal of haematology 129 (5), 631-643, 2005 | 135* | 2005 |
| Stem cell transplantation for chronic myeloid leukemia in children K Cwynarski, IAG Roberts, S Iacobelli, A van Biezen, R Brand, A Devergie, ... Blood 102 (4), 1224-1231, 2003 | 124 | 2003 |
| Primary plasma cell leukemia and autologous stem cell transplantation MB Drake, S Iacobelli, A van Biezen, C Morris, JF Apperley, ... Haematologica 95 (5), 804, 2010 | 106 | 2010 |
| Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies … N Gagelmann, DJ Eikema, S Iacobelli, L Koster, H Nahi, AM Stoppa, ... haematologica 103 (5), 890, 2018 | 103 | 2018 |
| Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma … HW Auner, S Iacobelli, G Sbianchi, C Knol-Bout, D Blaise, NH Russell, ... haematologica 103 (3), 514, 2018 | 91 | 2018 |
